findmyKOL

David Delurgio, MD

Enriched profile

Professor of Medicine · Emory University

ORCIDNPI
Region🇺🇸 Atlanta, GA · Southeast · United StatesSpecialtyClinical Cardiac ElectrophysiologyFocusCardiac Arrhythmias and Treatments+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

David Delurgio is Professor of Medicine at Emory University. OpenAlex indexes 139 publications with 12,036 citations (h-index 34); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Clinical Cardiac Electrophysiology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

David B. DeLurgio, MD, is Professor of Medicine at Emory University. The public record shows 139 publications with 12,036 citations (h-index 34), centered on Cardiac Arrhythmias and Treatments, Cardiac pacing and defibrillation studies, Atrial Fibrillation Management and Outcomes. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 25 companies.

  • Most recent indexed publication: 2026 · Europace
  • Top research focus: Cardiac Arrhythmias and Treatments
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 25 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Atrial Fibrillation3 trialsHeart Failure2 trialsSyncope1 trialSyncope, Vasovagal1 trial

Research focus

OpenAlex concept fingerprint
Cardiac Arrhythmias and TreatmentsCardiac pacing and defibrillation studiesAtrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmiasCardiac Valve Diseases and Treatments

Drugs & molecules

across trials, industry payments and publications
Eliquisgeneric · ApixabanClinical trialsIndustry payments13PublicationsVyndaqelgeneric · TafamidisClinical trialsIndustry payments10PublicationsXareltogeneric · RivaroxabanClinical trialsIndustry payments10Publications

Works with

trial sponsors and companies reporting payments
Boston Scientific CorporationClinical trials2Industry payments296AtriCure, Inc.Clinical trials1Industry payments228Abbott LaboratoriesClinical trialsIndustry payments197

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
139publications

Distinct works indexed by OpenAlex, matched via ORCID; 10 in PubMed.

12,036citations

Total citations across indexed works.

34h-index

Hirsch index (OpenAlex). i10-index 64.

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials
25companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

25 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    62.9%
    Beta blocker27.2%
    Sotalol42%Metoprolol Succinate39%Metoprolol Tartrate8%Carvedilol8%Atenolol2%Nebivolol Hcl2%
    Part D<11 patients
    Antiarrhythmic23.4%
    Flecainide Acetate59%Dofetilide16%Amiodarone Hcl13%Mexiletine Hcl5%Multaq3%Propafenone Hcl3%
    Part D<11 patients
  • Blood & clotting

    32.4%
    Factor Xa inhibitor30.8%
    Eliquis75%Xarelto25%
    Part D170 patients
    Direct thrombin inhibitors1%
    Dabigatran Etexilate100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    4%
    Aluminum Complex2%
    Sucralfate100%
    Part D47 patients
    Proton pump inhibitor1.3%
    Pantoprazole Sodium100%
    Part D30 patients
1 more therapeutic area behind the reveal.Reveal →
Where care is delivered (Part B)27.1% facility · 72.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Angel R. León53Mikhael F. El‐Chami37Faisal M. Merchant33

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/david-delurgio-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/david-delurgio-79969597

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • LinkedIn

    linkedin.com/in/david-delurgio-7a95b816

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com
2 more verified accounts behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Other

    news.emory.edu/stories/2014/06/saintjosephs_delurgio/index.html

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.emory.edu
  • Other

    afsymposium.com/david-b-de-lurgio-md-facc-fhrs

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →afsymposium.com
  • X / Twitter

    X/Twitter handle @DavidBDeLurgio

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    Clinical Cardiac Electrophysiology, American Board of Internal Medicine

    1998
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.emoryhealthcare.org
  • Board Certified

    Cardiovascular Disease, American Board of Internal Medicine

    1997
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.emoryhealthcare.org
  • Cardiac Electrophysiology Fellowship

    Emory University School of Medicine

    1996
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.emoryhealthcare.org
  • Cardiology Fellowship

    University of California Medical Center

    1995
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.emoryhealthcare.org
  • Internal Medicine Residency

    University of California Medical Center

    1993
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.emoryhealthcare.org
  • Board Certified

    Internal Medicine, American Board of Internal Medicine

    1993
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.emoryhealthcare.org
  • MD

    University of California, Los Angeles School of Medicine

    1990
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.emoryhealthcare.org

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
2 more affiliations behind the reveal.Reveal →

Media & interviews

press, podcasts and appearances
  • National Principal Investigator

    CONVERGE IDE Clinical Trial (AtriCure press release)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ir.atricure.com

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.